Kai Kupferschmidt

I’ve reported on infectious diseases for 15 years, but during the covid-19 pandemic and even more during the global outbreak of mpox clade IIb, I was shocked by the amount of misinformation I was seeing. Misinfo had always been part of any outbreak, but this felt different.

"Nearly 7 years after her first attempt to test Ebola prevention drugs, Jaspard is stunned by the sudden interest in the trial. “I've kept this project for all these years, despite the fact that a lot of people were saying it's not useful, you don't need to do this, go away,” she says."

science.org/content/articl…

One glimmer of hope in the Ebola response:
Within hours of the outbreak in DRC being declared, researchers convened to prepare drug trials.
A lot has changed on that front since the Ebola outbreak in West Africa a decade ago. But huge challenges remain…
My story in @ScienceMagazine

science.org/content/articl…

There is a LOT going on as researchers and public health experts are racing to respond to the #Ebola Bundibugyo outbreak in DRC and Uganda before it grows bigger.
My story in @ScienceMagazine is here:

science.org/content/articl…